These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6148878)

  • 21. Nadolol in essential tremor.
    Koller WC
    Neurology; 1983 Aug; 33(8):1076-7. PubMed ID: 6348587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative effects of ICI 118551 and propranolol on essential tremor.
    Jefferson D; Wharrad HJ; Birmingham AT; Patrick JM
    Br J Clin Pharmacol; 1987 Dec; 24(6):729-34. PubMed ID: 2894217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor.
    Teräväinen H; Huttunen J; Larsen TA
    Acta Neurol Scand; 1986 Jul; 74(1):34-7. PubMed ID: 2876576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 29. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J; Frishman WH
    N Engl J Med; 1981 Aug; 305(9):500-6. PubMed ID: 6114433
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nadolol in the preventive treatment of migraine].
    Szczudlik A
    Wiad Lek; 1984 Jul; 37(14):1087-92. PubMed ID: 6151319
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 32. Flunarizine and propranolol in the treatment of migraine.
    Ludin HP
    Headache; 1989 Apr; 29(4):219-24. PubMed ID: 2654068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study.
    Olsson JE; Behring HC; Forssman B; Hedman C; Hedman G; Johansson F; Kinnman J; Pålhagen SE; Samuelsson M; Strandman E
    Acta Neurol Scand; 1984 Sep; 70(3):160-8. PubMed ID: 6391066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nadolol eye drops in glaucoma and ocular hypertension: a controlled clinical study of dose response and duration of action.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):309-14. PubMed ID: 6119925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
    Burmeister WE; Reynolds RD; Lee RJ
    Eur J Pharmacol; 1981 Oct; 75(1):7-10. PubMed ID: 6119212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of resting tremor by beta-adrenergic blockade.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Chase TN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1173-7. PubMed ID: 6148881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
    Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.